SpliSense
PrivateLast Round
Grant
Jun 16, 2026
Total Funding Raised
$38.4M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
SpliSense is a biotechnology company that develops innovative RNA-based therapies using antisense oligonucleotides to treat cystic fibrosis and other genetic pulmonary diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SpliSense Comparables
Compare SpliSense with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Spirovant Sciences | 80% | |
| ReCode Therapeutics | 79% | |
| ProQR Therapeutics | 78% |
SpliSense Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 16, 2026 | ||||
| Grant | Apr 3, 2024 | ||||
| Series B | May 13, 2021 |
SpliSense Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Israel Biotech Fund | Series B, Grant |
| OrbiMed | Grant, Series B |
| Integra Holdings | Series B, Series A, Grant |
| Cystic Fibrosis Foundation | Series B, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 90% MoM.
- Jun 16, 2026
Raised $13M with Cystic Fibrosis Foundation leading.
Recent news
Latest coverage and updates
- receives_financingJun 16, 2026
Splisense Ltd. received financing of $13M in funding on Jun 16th '26.
SpliSense Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about SpliSense's valuation, stock price, and market status.
Is SpliSense a public or private company?
SpliSense is a private company.
What is the current stock price of SpliSense?
SpliSense is a private company with no public stock price. No recent secondary market data is available.
How much is SpliSense worth (valuation)?
Valuation information for SpliSense is not publicly available.
Can I buy SpliSense stock?
SpliSense shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was SpliSense's last funding round?
SpliSense's most recent funding round was Early Funding on June 16, 2026.
Who are the main investors in SpliSense?
Key investors in SpliSense include OrbiMed, Cystic Fibrosis Foundation.
Will SpliSense IPO soon?
No public IPO plans have been announced for SpliSense.
How can I track SpliSense secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor SpliSense's secondary market activity and sign up for updates.